Public Citizen scrutinizes the Most-Favoured Nation pricing deals between the Trump administration and 27 pharmaceutical companies, arguing claims about savings
AstraZeneca’s breast cancer drug Etcamah failed its first-line trial, SERENA-4, raising doubts about its potential as a frontline treatment for HR-positive pati
Novo Nordisk drops its full name to become 'Novo,' sharpening focus against Eli Lilly in weight loss and diabetes treatments amid slowing growth.
AstraZeneca's AZD5462 shows promise in Phase II trial for chronic heart failure, improving cardiac function via relaxin pathway.
© 2026 Vimeo Health. All rights reserved.
Theme by Auto UI Theme Builder.
